BMRN - BioMarin Pharmaceutical officer disposes stake worth $1.31M under trading plan
2023-12-15 12:00:57 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript
- Wells Fargo starts BioMarin at overweight, cites activist involvement
- BioMarin could be very 'digestible' to larger cap peers in US/Europe - analyst
For further details see:
BioMarin Pharmaceutical officer disposes stake worth $1.31M under trading plan